MDEChem, Inc.
MDKM
Other OTC0.00
USD
+0.00
- -
ISIN
US5828263013
Return %
Stock
S&P500
1Y
- -
19.01
3Y
-70.00
65.48
5Y
-98.57
72.20
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Paul W. Sack
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 923 10th Street Floresville TX United States of America 78114
- IPO Date
- Sep 14, 1998
- Website
- mdechem.com
- Similar Companies
- Business
- MDEChem, Inc. (MDKM) develops and markets pharmaceutical and chemical products focused on skin care treatments and oil recovery solutions. The company offers MaxHeal skin restoration gel, a non-steroidal anti-inflammatory compound that provides instant relief for minor cuts, scrapes, minor burns, sunburn, abrasions, and itchy bites from chiggers, mosquitoes, sand fleas, black flies, and other insects; and SANDKLENE 950, a non-toxic chemical composition used in the recovery of oil from tar sands and oil sands. Founded in 1996 and headquartered in Floresville, Texas, MDEChem operates primarily in the United States, targeting consumer healthcare markets for its pharmaceutical products and industrial sectors for its chemical solutions. No significant recent partnerships, acquisitions, funding rounds, new product launches, or major strategic shifts have been publicly reported for the company in the last one to two years.